VLP Therapeutics
PrivateLast Round
Grant
Dec 11, 2025
Total Funding Raised
$41.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
VLP Therapeutics is a biotechnology company that develops next-generation vaccine technologies to treat cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VLP Therapeutics Comparables
Compare VLP Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TechnoVax, Inc. | 86% | |
| VLP Biotech, Inc. | 86% | |
| SpyBiotech | 84% |
VLP Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 11, 2025 | ||||
| Grant | Mar 17, 2025 | ||||
| VC Round | Nov 8, 2023 | ||||
| Grant | Oct 3, 2022 | ||||
| Series A Extension | Dec 27, 2021 | ||||
Series A | Mar 15, 2021 |
VLP Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Grant |
| National Cancer Institute | Grant |
| Phoenixi Co., Ltd. | VC Round |
| Sumitomo Mitsui Trust Bank | VC Round |
| United States Department of Defense | Grant |
| MUFG Bank | VC Round, Series A Extension |
| 株式会社FFGベンチャービジネスパートナーズ | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors increased 48% MoM, reaching 2.4K.
- Apr 18, 2026
Monthly visitors increased 74% MoM.
VLP Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VLP Therapeutics's valuation, stock price, and market status.
Is VLP Therapeutics a public or private company?
VLP Therapeutics is a private company.
What is the current stock price of VLP Therapeutics?
VLP Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is VLP Therapeutics worth (valuation)?
Valuation information for VLP Therapeutics is not publicly available.
Can I buy VLP Therapeutics stock?
VLP Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VLP Therapeutics's last funding round?
VLP Therapeutics's most recent funding round was Grant on December 11, 2025.
Who are the main investors in VLP Therapeutics?
Key investors in VLP Therapeutics include MUFG Bank, Global Health Innovative Technology Fund, Bill & Melinda Gates Foundation, Miyako Capital.
Will VLP Therapeutics IPO soon?
No public IPO plans have been announced for VLP Therapeutics.
How can I track VLP Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VLP Therapeutics's secondary market activity and sign up for updates.